Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

Quick Access

Favorites
Most Used

All Specialties

OpiCalc Logo
Clinical CalculatorsDrugsGuidelines
SpecsDrugsGuides
ABC-AF Bleeding ScoreABC-AF Stroke ScoreABCD2 ScoreADD-RSAortic Valve Calcium ScoreAPPLE ScoreASCVD (Pooled Cohort)AVA (Continuity Equation)BAG-AHF ScoreBiplane Simpson EFBlood Pressure PercentilesBrugada Criteria (VT vs SVT)Cardiac Output IndexCHA2DS2-VAScCHADS2Cornell Voltage CriteriaCRUSADE Bleeding ScoreDAPT ScoreDASIDuke Treadmill ScoreE/A RatioEDACS ScoreEHMRGEHRA ScoreEmbolic Risk ScoreEROA (PISA Method)FFR (Fractional Flow Reserve)Fick Cardiac OutputFramingham 10-Year RiskFriedewald LDL EquationGorlin EquationGRACE ScoreGupta MICA (NSQIP)GWTG-HF ScoreH2FPEF ScoreHakki FormulaHAS-BLEDHEART PathwayHEART ScoreHEMORR2HAGEShs-Troponin 0h/1h ESC AlgorithmiFRINTERCHEST ScoreKillip ClassificationLee's RCRILV Mass IndexLV Stroke Work IndexMAGGIC Risk ScoreMAP CalculatorMartin/Hopkins LDLModified Duke CriteriaModified Sgarbossa CriteriaMVA (Pressure Half-Time)Non-HDL CholesterolNT-proBNP Age-Adjusted ThresholdsORBIT ScoreOttawa Heart Failure RiskPREVENT EquationsPulse PressurePVR CalculatorPVR IndexQRISK3QTc (Bazett)QTc (Fridericia)REVEAL 2.0 ScoreREVEAL Lite 2Reynolds Risk ScoreROSIRVSP CalculatorSchwartz Score (LQTS)SCORE2Seattle Heart Failure Model (SHFM)Sgarbossa CriteriaShock IndexSokolow-Lyon VoltageStroke Volume IndexSVR CalculatorSYNTAX ScoreSYNTAX Score IITAPSETeichholz FormulaTIMI (STEMI)TIMI (UA/NSTEMI)Troponin Delta CalculatorValvular GradientsVancouver Chest Pain RuleVereckei AlgorithmWATCHDM ScoreWilkins ScoreWood Units Calculator
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2026

•

All Rights Reserved

AVA (Continuity Equation)

AVA (Continuity Equation): Calculates aortic valve area from Doppler echocardiography to assess aortic stenosis severity.

cm
cm
cm
m2

Formula

AVA = (π/4 × LVOT d2) × (VTILVOT / VTIAV)

Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

When to Use

Quantification of aortic stenosis severity on TTE/TEE
Decision-making for AVR vs. conservative management
Diagnostic workup of murmurs
Serial assessment of severe AS progression
Discordant gradient/area findings (low-flow states)

Key Points

Recommended by ACC/AHA and ESC guidelines as gold standard for AS quantification
More reliable than simpler planimetered area in off-axis imaging
Critical in low-gradient AS scenarios for true area determination
Requires good image quality (LVOT visualization + aortic valve alignment)

How it Works

Formula

AVA = (π/4 × LVOT diameter2) × (LVOT VTI / Aortic Valve VTI) Simplified: AVA = (π/4 × LVOT d2) × (V1 / V2) Where d = LVOT diameter (parasternal long axis), VTI = velocity-time integral (PWD or CWD)

Severity Classification (Aortic Stenosis)

AVA (cm2)Mean Gradient (mmHg)Classification
>1.5<25Mild
1.0–1.525–40Moderate
<1.0>40Severe
<0.6VariableVery Severe (operative threshold)

Clinical Pearls

Technical Considerations

LVOT diameter must be measured in systole at base of anterior mitral leaflet
Undersizing LVOT diameter → underestimates AVA; oversizing → overestimates
Off-axis CWD recording at aortic valve → artificially elevated velocities → artificially reduced AVA
VTI should be traced from the same cardiac cycle on both LVOT (PWD) and AV (CWD)

Clinical Pearls

In low-flow/low-gradient AS (LVOL EF, small LV), continuity equation AVA best reflects true anatomy
Indexed AVA (AVA / BSA) helps distinguish true severe AS in small-bodied patients
Discordance between continuity AVA and planimetry → TEE for clarification
Serial AVA >0.1 cm2/year decline signals rapid progression; consider earlier AVR

Next Steps

Mild AS (AVA >1.5 cm2)

Reinforce endocarditis prophylaxis and lifestyle modification
3–5 year echo surveillance
No restriction on activity in asymptomatic patients
Annual cardiology follow-up if additional risk factors

Moderate AS (AVA 1.0–1.5 cm2)

Annual TTE with symptom inquiry
Consider stress echo if symptoms equivocal
Monitor for other valve disease, LV dysfunction
Reinforce activity modification if symptoms develop

Severe AS (AVA <1.0 cm2)

Refer for cardiothoracic surgery evaluation
Symptomatic patients = surgical candidate (SAVR or TAVR)
Asymptomatic with LV EF drop, rapid progression, or low gradient → consider AVR regardless
Stress testing may be warranted if symptoms unclear and AVA borderline

Complementary Calculators

Biplane Simpson EF
TAPSE (RV Systolic Function)
MVA (Pressure Half-Time)
EROA (PISA Method)
LV Mass Index

The Evidence

Validation

ESC/EACTS Guidelines for the management of valvular heart disease.

Baumgartner H et al. • EuroIntervention.. 2017;e563. The primary European standard for AS grading.

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease.

Nishimura RA et al. • Circulation.. 2014;e521-e643. The primary American society recommendations.

Last Comprehensive Review: 2026-07-17

Guidelines & Evidence

Verified

Last Review: 2026-07-17

When to Use

When to Use

Quantification of aortic stenosis severity on TTE/TEE
Decision-making for AVR vs. conservative management
Diagnostic workup of murmurs
Serial assessment of severe AS progression
Discordant gradient/area findings (low-flow states)

Key Points

Recommended by ACC/AHA and ESC guidelines as gold standard for AS quantification
More reliable than simpler planimetered area in off-axis imaging
Critical in low-gradient AS scenarios for true area determination
Requires good image quality (LVOT visualization + aortic valve alignment)

How it Works

Formula

AVA = (π/4 × LVOT diameter2) × (LVOT VTI / Aortic Valve VTI) Simplified: AVA = (π/4 × LVOT d2) × (V1 / V2) Where d = LVOT diameter (parasternal long axis), VTI = velocity-time integral (PWD or CWD)

Severity Classification (Aortic Stenosis)

AVA (cm2)Mean Gradient (mmHg)Classification
>1.5<25Mild
1.0–1.525–40Moderate
<1.0>40Severe
<0.6VariableVery Severe (operative threshold)

Clinical Pearls

Technical Considerations

LVOT diameter must be measured in systole at base of anterior mitral leaflet
Undersizing LVOT diameter → underestimates AVA; oversizing → overestimates
Off-axis CWD recording at aortic valve → artificially elevated velocities → artificially reduced AVA
VTI should be traced from the same cardiac cycle on both LVOT (PWD) and AV (CWD)

Clinical Pearls

In low-flow/low-gradient AS (LVOL EF, small LV), continuity equation AVA best reflects true anatomy
Indexed AVA (AVA / BSA) helps distinguish true severe AS in small-bodied patients
Discordance between continuity AVA and planimetry → TEE for clarification
Serial AVA >0.1 cm2/year decline signals rapid progression; consider earlier AVR

Next Steps

Mild AS (AVA >1.5 cm2)

Reinforce endocarditis prophylaxis and lifestyle modification
3–5 year echo surveillance
No restriction on activity in asymptomatic patients
Annual cardiology follow-up if additional risk factors

Moderate AS (AVA 1.0–1.5 cm2)

Annual TTE with symptom inquiry
Consider stress echo if symptoms equivocal
Monitor for other valve disease, LV dysfunction
Reinforce activity modification if symptoms develop

Severe AS (AVA <1.0 cm2)

Refer for cardiothoracic surgery evaluation
Symptomatic patients = surgical candidate (SAVR or TAVR)
Asymptomatic with LV EF drop, rapid progression, or low gradient → consider AVR regardless
Stress testing may be warranted if symptoms unclear and AVA borderline

Complementary Calculators

Biplane Simpson EF
TAPSE (RV Systolic Function)
MVA (Pressure Half-Time)
EROA (PISA Method)
LV Mass Index

The Evidence

Validation

ESC/EACTS Guidelines for the management of valvular heart disease.

Baumgartner H et al. • EuroIntervention.. 2017;e563. The primary European standard for AS grading.

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease.

Nishimura RA et al. • Circulation.. 2014;e521-e643. The primary American society recommendations.

Last Comprehensive Review: 2026-07-17

Recent Journal Updates

JAMAJul 21, 2026
US Food Swamps Have Increased as Food Deserts Remain Static

Clinical Context

We think this might be relevant to the clinical guidance for Aortic Valve Area (Continuity Equation).

WHO NewsJul 20, 2026
Road deaths fall by 21% globally but stronger action is needed to save lives

Clinical Context

We think this might be relevant to the clinical guidance for Aortic Valve Area (Continuity Equation).

FDA MedWatchJul 13, 2026
Pulmonary Valve Catheter Delivery System Recall: Medtronic Removes Harmony Delivery Catheter System (DCS)

Clinical Context

We think this might be relevant to the clinical guidance for Aortic Valve Area (Continuity Equation).